These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18780875)

  • 21. Histone deacetylases 1 and 2 inhibition suppresses cytokine production and osteoclast bone resorption in vitro.
    Algate K; Haynes D; Fitzsimmons T; Romeo O; Wagner F; Holson E; Reid R; Fairlie D; Bartold P; Cantley M
    J Cell Biochem; 2020 Jan; 121(1):244-258. PubMed ID: 31222845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone hyperacetylation is associated with amelioration of experimental colitis in mice.
    Glauben R; Batra A; Fedke I; Zeitz M; Lehr HA; Leoni F; Mascagni P; Fantuzzi G; Dinarello CA; Siegmund B
    J Immunol; 2006 Apr; 176(8):5015-22. PubMed ID: 16585598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced CXCL10 production by immature human dendritic cells.
    McIlroy A; Caron G; Blanchard S; Frémaux I; Duluc D; Delneste Y; Chevailler A; Jeannin P
    Immunology; 2006 Apr; 117(4):507-16. PubMed ID: 16556265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG mice.
    Misaki K; Morinobu A; Saegusa J; Kasagi S; Fujita M; Miyamoto Y; Matsuki F; Kumagai S
    Arthritis Res Ther; 2011 May; 13(3):R77. PubMed ID: 21592365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern.
    Ebner S; Hofer S; Nguyen VA; Fürhapter C; Herold M; Fritsch P; Heufler C; Romani N
    J Immunol; 2002 Jun; 168(12):6199-207. PubMed ID: 12055233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibiting histone deacetylase 1 suppresses both inflammation and bone loss in arthritis.
    Cantley MD; Fairlie DP; Bartold PM; Marino V; Gupta PK; Haynes DR
    Rheumatology (Oxford); 2015 Sep; 54(9):1713-23. PubMed ID: 25832610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase inhibitors suppress immune activation in primary mouse microglia.
    Kannan V; Brouwer N; Hanisch UK; Regen T; Eggen BJ; Boddeke HW
    J Neurosci Res; 2013 Sep; 91(9):1133-42. PubMed ID: 23686642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylase inhibition is cytotoxic to oligodendrocyte precursor cells in vitro and in vivo.
    Dincman TA; Beare JE; Ohri SS; Gallo V; Hetman M; Whittemore SR
    Int J Dev Neurosci; 2016 Nov; 54():53-61. PubMed ID: 27587342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model.
    Choi Y; Park SK; Kim HM; Kang JS; Yoon YD; Han SB; Han JW; Yang JS; Han G
    Exp Mol Med; 2008 Oct; 40(5):574-81. PubMed ID: 18985016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DC-SIGN ligation greatly affects dendritic cell differentiation from monocytes compromising their normal function.
    Svajger U; Obermajer N; Anderluh M; Kos J; Jeras M
    J Leukoc Biol; 2011 Jun; 89(6):893-905. PubMed ID: 21447648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of monomethylfumarate on dendritic cell differentiation.
    Litjens NH; Rademaker M; Ravensbergen B; Thio HB; van Dissel JT; Nibbering PH
    Br J Dermatol; 2006 Feb; 154(2):211-7. PubMed ID: 16433787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12.
    Zou W; Borvak J; Marches F; Wei S; Galanaud P; Emilie D; Curiel TJ
    J Immunol; 2000 Oct; 165(8):4388-96. PubMed ID: 11035076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression.
    Inoue K; Kobayashi M; Yano K; Miura M; Izumi A; Mataki C; Doi T; Hamakubo T; Reid PC; Hume DA; Yoshida M; Aird WC; Kodama T; Minami T
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2652-9. PubMed ID: 17008592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.
    Mishra N; Reilly CM; Brown DR; Ruiz P; Gilkeson GS
    J Clin Invest; 2003 Feb; 111(4):539-52. PubMed ID: 12588892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E-prostanoid (EP)2/EP4 receptor-dependent maturation of human monocyte-derived dendritic cells and induction of helper T2 polarization.
    Kubo S; Takahashi HK; Takei M; Iwagaki H; Yoshino T; Tanaka N; Mori S; Nishibori M
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1213-20. PubMed ID: 14872092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirement of histone deacetylase activity for signaling by STAT1.
    Klampfer L; Huang J; Swaby LA; Augenlicht L
    J Biol Chem; 2004 Jul; 279(29):30358-68. PubMed ID: 15123634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
    Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
    Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients.
    Gillespie J; Savic S; Wong C; Hempshall A; Inman M; Emery P; Grigg R; McDermott MF
    Arthritis Rheum; 2012 Feb; 64(2):418-22. PubMed ID: 21952924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1.
    Leng C; Gries M; Ziegler J; Lokshin A; Mascagni P; Lentzsch S; Mapara MY
    Exp Hematol; 2006 Jun; 34(6):776-87. PubMed ID: 16728283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
    Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.